Keywords: anesta, corp, submits, nda, fda, actiq, corporation

Anesta Corp Submits NDA To FDA For Actiq

Article | 25 November 1996

Print This

- Anesta Corporation has submitted a New Drug Application to the US Food and Drug Administration for Actiq (fentanyl citrate), an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in